Christina Bergmann Selected Research

Christina Bergmann Research Topics

Disease

18	Fibrosis (Cirrhosis) 03/2024 - 12/2011
18	Systemic Scleroderma (Systemic Sclerosis) 03/2024 - 12/2011
3	Bronchiolitis Obliterans Syndrome 03/2024 - 06/2017
3	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2023 - 03/2021
2	Disease Progression 03/2021 - 11/2020
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 08/2017
1	Idiopathic Pulmonary Fibrosis 03/2024
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2024
1	Rheumatoid Arthritis 01/2023
1	Vasculitis (Vasculitides) 01/2023
1	Diabetes Mellitus 01/2022
1	Chronic Pancreatitis 12/2021
1	Neoplasms (Cancer) 01/2021
1	Immunoglobulin G4-Related Disease 11/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Vascular Remodeling 01/2020
1	Psoriatic Arthritis 06/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2017

Drug/Important Bio-Agent (IBA)

8	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 12/2011
4	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2024 - 01/2020
4	CollagenIBA 01/2021 - 12/2011
3	68Ga-FAPIIBA 07/2021 - 11/2020
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021 - 06/2017
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
3	indium-bleomycinIBA 08/2017 - 12/2011
2	LigandsIBA 03/2024 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 07/2023 - 10/2018
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 01/2018
2	CytokinesIBA 01/2020 - 01/2020
1	Chimeric Antigen ReceptorsIBA 02/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024
1	fludarabineIBA 02/2024
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	A-factor (Streptomyces)IBA 01/2023
1	mitochondrial transcription factor AIBA 01/2022
1	EnzymesIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Prolyl OligopeptidasesIBA 03/2021
1	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2021
1	GlucocorticoidsIBA 11/2020
1	Antifibrotic AgentsIBA 11/2020
1	Adenosine DeaminaseIBA 01/2020
1	DNA Methyltransferase 3AIBA 01/2020
1	PPAR gammaIBA 01/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020
1	pegademase bovine (pegADA)FDA Link 01/2020
1	SR18292IBA 01/2020
1	Soluble Guanylyl CyclaseIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 01/2018
1	Histone DemethylasesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2017
1	Interleukin-6 (Interleukin 6)IBA 06/2017
1	apremilastIBA 06/2017
1	RolipramIBA 06/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 06/2017
1	Glycogen Synthase KinasesIBA 12/2011
1	Glycogen Synthase Kinase 3IBA 12/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2021